These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9207984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.
    Avellone G, Di Garbo V, Cordova R, Piliego T, Raneli G, De Simone R, Bompiani GD.
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):543-8. PubMed ID: 7578896
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR, Jeng CY, Sheu WH, Lee MM, Huang SH, Shieh SM.
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.
    Rubins HB, Robins SJ.
    J Intern Med; 1992 Apr; 231(4):421-6. PubMed ID: 1588269
    [Abstract] [Full Text] [Related]

  • 6. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia.
    Asplund-Carlson A.
    J Cardiovasc Risk; 1996 Aug; 3(4):385-90. PubMed ID: 8946270
    [Abstract] [Full Text] [Related]

  • 9. Coagulofibrinolytic assessment of effects of bezafibrate on hypertriglyceridemia in postmenopausal women.
    Ushiroyama T, Ikeda A, Higashio S, Ueki M.
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):709-14. PubMed ID: 11132648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ, Pei D, Wu DA, Kuo SW, Fuh MM, Jeng C.
    J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S, Kudchodkar BJ, Clearfield MB, Lacko AG.
    Artery; 1992 Feb; 19(6):353-66. PubMed ID: 1471924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.
    Zema MJ.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):640-6. PubMed ID: 10716466
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.